Healthcare Services
Healthcare
How NephroPlus is expanding from cash raised recently; eyes $30M more next year
Hyderabad-based dialysis chain Nephrocare Health Services Pvt Ltd, which runs a dialysis chain under the brand NephroPlus and raised $10 ......
Healthcare
India Value Fund buying 10% in Biocon's research arm Syngene for $62M
Mid-market buyout specialist private equity firm India Value Fund Advisors (IVFA) is picking 10 per cent stake in Syngene International ......
Healthcare
Aster DM Healthcare appoints bankers for IPO
Aster DM Healthcare, which has a chain of hospitals spread across India and the Middle East and has been planning ......
Healthcare
Fortis selling Singapore-based diagnostics arm RadLink to Malaysia's IHH for $109M
Fortis Healthcare has struck a deal to sell its entire holding in Singapore-based healthcare services unit RadLink-Asia Pte Ltd and ......
Healthcare
Former Paras Pharma promoter enters diagnostics business through Sterling Addlife
Gujarat-based healthcare provider Sterling Addlife India Ltd, which operates a chain of hospitals under Sterling Hospitals banner, is stepping foot ......
Healthcare
Deep Chand Dialysis Centre raising funds from Pragati India Fund
Delhi-based DCDC Health Services Pvt Ltd, which runs dialysis centres under its brand Deep Chand Dialysis Centre (DCDC), has struck ......
Healthcare
Columbia Asia to invest $150M to expand hospital chain in Southeast Asia, India
Columbia Asia, a two-decade-old chain of hospitals headquartered in Malaysia with 27 facilities across India, Malaysia, Vietnam and Indonesia, said ......
Healthcare
Everstone Capital in talks to exit Global Hospitals
Private equity firm Everstone Capital, which had picked significant minority stake in Hyderabad-based Ravindranath GE Medical Associates Ltd, is looking ......
Healthcare
Fortis Healthcare CFO Sandeep Puri steps down
Sandeep Puri, group CFO of Fortis Healthcare Ltd, the second-largest hospital chain in the country, has resigned from the company, ......
Healthcare
GE Capital clocks almost 2x as Biocon buys back its stake in Syngene for $35M
Drug maker Biocon today acquired GE Capital's entire 7.69 per cent stake in its research services subsidiary Syngene International for ......
Most Popular
Google News
Follow VCCircle on Google News for the latest updates on Business and Startup News